The Medipass operation achieved a revenue run rate for the 12-months to end February 2021 of
approximately $1.8 million and generated an EBITDA loss over that 12-month period of approximately
$1.5 million.
Obviously a strategic move, and important. It will be interesting to see what Tyro financials look like at year end.
Ann: Tyro to Acquire Health Fintech - Medipass, page-7
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.035(3.41%) |
Mkt cap ! $556.4M | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.07 | $1.02 | $2.091M | 1.992M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40000 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 133347 | 11 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| TYR (ASX) Chart |